Patents by Inventor Jesus Seco MORAL

Jesus Seco MORAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER THERAPEUTICS
    Publication number: 20240327456
    Abstract: Therapeutic compounds of the invention comprise peptidomimetics, including those of formula (I), which has been prepared using solid-phase peptide synthesis. It is useful in the treatment of a cancer, including, for the treatment of a pancreatic cancer, a lung cancer or a colorectal cancer, further, including, a treatment for a pancreatic ductal adenocarcinoma.
    Type: Application
    Filed: July 6, 2022
    Publication date: October 3, 2024
    Applicant: UNIVERSITAT DE BARCELONA
    Inventors: Nieves AGELL JANE, Montserrat JAUMOT PIJOAN, Debora CABOT ROMERO, Sonia BRUN LOZANO, Baraa ABUASAKER, Francesc RABANAL ANGLADA, Chiara PALLARA, Jesus SECO MORAL, Josep RIVAS SANTOS, Roger PRADES COSANO, Teresa TARRAGO CLUA
  • Modified peptides for use in treating neurodegenerative disorders
    Patent number: 11939398
    Abstract: The invention relates to neurodegenerative disorders, and in particular to novel peptides, peptidomimetics, compositions, therapies and methods for treating such conditions, for example Alzheimer's disease.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: March 26, 2024
    Assignee: Neuro-Bio Ltd
    Inventors: Susan Greenfield, Sara Garcia-Rates, Jesus Seco Moral, Roger Prades Cosano
  • MODIFIED PEPTIDES FOR USE IN TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20210094983
    Abstract: The invention relates to neurodegenerative disorders, and in particular to novel peptides, peptidomimetics, compositions, therapies and methods for treating such conditions, for example Alzheimer's disease.
    Type: Application
    Filed: August 16, 2017
    Publication date: April 1, 2021
    Inventors: Susan GREENFIELD, Sara GARCIA-RATES, Jesus Seco MORAL, Roger Prades COSANO
  • Gelatinase inhibitors and use thereof
    Patent number: 10414797
    Abstract: New gelatinase inhibitors, processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy and/or prophylaxis of conditions wherein inhibition of gelatinases is useful such as epilepsy, schizophrenia, Alzheimer disease, autism (in particular associated to fragile X syndrome), mental retardation, mood disorders such as bipolar disorders, depression, vascular diseases such as ischemic stroke and atherosclerosis, inflammatory diseases such as multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease, drug addiction, neuropathic pain, lung diseases such as asthma and chronic obstructive pulmonary disease, cancer and sepsis.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: September 17, 2019
    Assignee: Iproteos S.L
    Inventors: Roger Prades Cosano, Jésus Seco Moral, María Teresa Tarragó Clua
  • GELATINASE INHIBITORS AND USE THEREOF
    Publication number: 20180319839
    Abstract: New gelatinase inhibitors, processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy and/or prophylaxis of conditions wherein inhibition of gelatinases is useful such as epilepsy, schizophrenia, Alzheimer disease, autism (in particular associated to fragile X syndrome), mental retardation, mood disorders such as bipolar disorders, depression, vascular diseases such as ischemic stroke and atherosclerosis, inflammatory diseases such as multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease, drug addiction, neuropathic pain, lung diseases such as asthma and chronic obstructive pulmonary disease, cancer and sepsis.
    Type: Application
    Filed: November 15, 2016
    Publication date: November 8, 2018
    Applicant: Iproteos S.L
    Inventors: Roger Prades Cosano, Jésus Seco Moral, María Teresa Tarragó Clua